Tretinoin
- Product NDC
- 72578-155
- Requested package NDC
- 72578-155-08
- 11-digit product format
- 725780155
- Labeler code
- 72578
- Product ID
- 72578-155_22150db5-d543-419f-bc09-a3280e19777b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tretinoin
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- Viona Pharmaceuticals Inc
- Application
- ANDA218560
- Marketing category
- ANDA
- Marketing start
- 2026-10-01
- Substance
- TRETINOIN
- Active strength
- .25 mg/g
- Pharmacologic classes
- Retinoid [EPC], Retinoids [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218560-001 | TRETINOIN | TRETINOIN | 0.025% | CREAM / TOPICAL | AB | 2026-09-15 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A218560-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A218560-001 | TRETINOIN | 0.025% | CREAM / TOPICAL | AB | 2026-09-15 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A218560-001 | TRETINOIN | 0.025% | CREAM / TOPICAL | AB | 2026-09-15 | c2088c7a36db… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A218560-001 | AB | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A218560-001 | AB | 1 | c2088c7a36db… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tretinoin
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TRETINOIN | .25 mg/g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 5688UTC01R | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 106302 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 946e67e7-458e-4607-b5f9-d5f6e021f7bd | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tretinoin | TRETINOIN | Zydus Lifesciences Limited | 332c2dfd-897a-489f-90b7-6957573558ef | 2026-09-30 | 218560 ANDA218560 | |
| Tretinoin | TRETINOIN | Viona Pharmaceuticals Inc | 946e67e7-458e-4607-b5f9-d5f6e021f7bd | 2026-09-30 | Warnings, Adverse reactions | 218560 ANDA218560 72578-155-08 72578-155 72578015508 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 72578-155-08 | 72578015508 | 1 TUBE in 1 CARTON (72578-155-08) / 45 g in 1 TUBE | 1 tube | 2026-10-01 | No | No | Current |